| Old Articles: <Older 54271-54280 Newer> |
|---|
 |
The Motley Fool
December 20, 2011
Luke Timmerman |
Amgen, Watson Strike $400M Deal for Biosimilar Cancer Drugs What does this important collaboration mean for biosimilars?   |
The Motley Fool
December 20, 2011
Brian D. Pacampara |
Salix Pharmaceuticals Shares Popped: What You Need to Know Shares of drugmaker Salix Pharmaceuticals climbed as high as 10.5% on Tuesday after the company reported positive phase-3 data for an oral version of its constipation treatment, Relistor. |
The Motley Fool
December 20, 2011
Austin Smith |
Coffee Holding: 2012 Preview What to expect out of JVA in 2012. |
The Motley Fool
December 20, 2011
Neha Chamaria |
Joy Global Lives Up to Its Name Joy's good performance and strong growth are impressive. |
The Motley Fool
December 20, 2011
Keki Fatakia |
Esterline Revenues Take Off, Earnings Stutter Esterline posts higher fourth-quarter revenues, but with significantly lower profits. |
The Motley Fool
December 20, 2011
Seth Jayson |
Joy Global Increases Sales but Misses Estimates Anyway For the quarter ended Oct. 28, Joy Global missed slightly on revenues and missed on earnings per share. |
The Motley Fool
December 20, 2011
Alex Planes |
Kansas Has a Fracking Good Time With Oil and Gas Exploration New plans for south-central Kansas could expand the pie for several companies. |
The Motley Fool
December 20, 2011
Seth Jayson |
Fool Cheat Sheet: Red Hat Earnings For the quarter ended Nov. 30, Red Hat met expectations on revenues and beat expectations on earnings per share. |
The Motley Fool
December 20, 2011
Anders Bylund |
TransAtlantic Petroleum Shares Jumped: What You Need to Know Shares of oil and natural gas producer TransAtlantic Petroleum jumped as much as 10.4% today on brisk volume. |
The Motley Fool
December 20, 2011
Isac Simon |
1 Natural Gas Stock for 2012 and Beyond A company with solid fundamentals that should look good for a long time to come. |
| <Older 54271-54280 Newer> Return to current articles. |
